Frequently Asked Questions
- Where is NEMOS available?
NEMOS is approved for the European market only.*
The device is available in Germany, Austria and Italy. Information on the availability in other European countries is available on request.
* All countries of the European Union and Switzerland
- Who is suitable for t-VNS therapy with NEMOS?
Patients decide together with their consultant doctor whether the therapy is suitable or not.
The NEMOS device is not certified for treating patients during pregnancy, or for patients with active implants (such as a cardiac pacemaker, or a cochlear implant).
- How does NEMOS work?
The transcutaneous vagus nerve stimulator NEMOS consists of a stimulation unit and a dedicated ear electrode. The stimulation unit, having approximately the size of a common mobile phone, sends out the electrical impulses. It is connected with the ear electrode, which patients wear like an earphone. The impulses are transferred via the ear electrode through the skin to a branch of the vagus nerve.
- How often do I have to use NEMOS?
The treatment with NEMOS is carried out autonomously by patients in sessions lasting approximately 4 hours per day.
- Which side effects may occur?
t-VNS is a therapeutic alternative with minor side effects. An analysis of data from over 300 patients and volunteers, who participated in studies of t-VNS, showed potential side effects that include itching, discomfort in the area of the outer ear and local pain at the stimulation side. These side effects usually disappear soon after stopping the stimulation.*
* Vigilance data cerbomed GmbH
- Can I stop using medications if I decide to use t-VNS?
t-VNS is a complementary therapy to medical treatment. Only your consultant doctor can decide whether you can stop or reduce medications.
- How long do I have to use t-VNS?
Like most pharmaceutical and neuromodulatory treatments for epilepsies, t-VNS is a long term therapy. You will get further information from your consultant doctor.
- How long does it take until the effect of t-VNS occurs?
Like most pharmaceutical and neuromodulatory treatments for epilepsies, t-VNS is not an acute therapy. Even if you respond to therapy with NEMOS, the effect may occur with a latency of some weeks to a few months.
- What can I do if I don’t respond to t-VNS?
Like in all other therapies there can never be a guarantee of success for a treatment using NEMOS. It is possible that some patients will not respond sufficiently to the therapy. Such patients can return the device after 6 months, for a partial refund of the purchase price.
NEMOS® - for treatment of drug-resistant epilepsy
Please download our brochure for patients and family.
Please note: NEMOS® is not cleared or approved for use in the U.S.